Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.21
BAXS's Cash to Debt is ranked higher than
50% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.81 vs. BAXS: 0.21 )
BAXS' s 10-Year Cash to Debt Range
Min: 0.21   Max: No Debt
Current: 0.21

Equity to Asset 0.55
BAXS's Equity to Asset is ranked higher than
65% of the 297 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. BAXS: 0.55 )
BAXS' s 10-Year Equity to Asset Range
Min: -1.48   Max: 0.97
Current: 0.55

-1.48
0.97
F-Score: 3
Z-Score: -7.79
M-Score: 99999999.99
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -169.31
BAXS's Operating margin (%) is ranked lower than
52% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.05 vs. BAXS: -169.31 )
BAXS' s 10-Year Operating margin (%) Range
Min: -360.04   Max: -60.47
Current: -169.31

-360.04
-60.47
Net-margin (%) -172.35
BAXS's Net-margin (%) is ranked lower than
52% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.65 vs. BAXS: -172.35 )
BAXS' s 10-Year Net-margin (%) Range
Min: -343.23   Max: -52.07
Current: -172.35

-343.23
-52.07
ROE (%) -108.76
BAXS's ROE (%) is ranked lower than
51% of the 289 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. BAXS: -108.76 )
BAXS' s 10-Year ROE (%) Range
Min: -141.39   Max: -8.63
Current: -108.76

-141.39
-8.63
ROA (%) -65.39
BAXS's ROA (%) is ranked lower than
52% of the 297 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.19 vs. BAXS: -65.39 )
BAXS' s 10-Year ROA (%) Range
Min: -92.65   Max: -8.34
Current: -65.39

-92.65
-8.34
ROC (Joel Greenblatt) (%) -591.61
BAXS's ROC (Joel Greenblatt) (%) is ranked lower than
52% of the 295 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.08 vs. BAXS: -591.61 )
BAXS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1373.08   Max: -180.52
Current: -591.61

-1373.08
-180.52
Revenue Growth (%) -27.00
BAXS's Revenue Growth (%) is ranked higher than
51% of the 274 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. BAXS: -27.00 )
BAXS' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 24.4
Current: -27

0
24.4
EBITDA Growth (%) -5.70
BAXS's EBITDA Growth (%) is ranked higher than
62% of the 237 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.90 vs. BAXS: -5.70 )
BAXS' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 53.4
Current: -5.7

0
53.4
EPS Growth (%) -3.30
BAXS's EPS Growth (%) is ranked higher than
66% of the 239 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.80 vs. BAXS: -3.30 )
BAXS' s 10-Year EPS Growth (%) Range
Min: -33.9   Max: 52.9
Current: -3.3

-33.9
52.9
» BAXS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

BAXS Guru Trades in Q3 2013

Jim Simons 332,475 sh (-4.24%)
» More
Q4 2013

BAXS Guru Trades in Q4 2013

Jim Simons 389,800 sh (+17.24%)
» More
Q1 2014

BAXS Guru Trades in Q1 2014

Jim Simons 260,683 sh (-33.12%)
» More
Q2 2014

BAXS Guru Trades in Q2 2014

Jim Simons 124,100 sh (-52.39%)
» More
» Details

Insider Trades

Latest Guru Trades with BAXS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.75
BAXS's P/B is ranked higher than
96% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.02 vs. BAXS: 0.75 )
BAXS' s 10-Year P/B Range
Min: 0.74   Max: 4.58
Current: 0.75

0.74
4.58
P/S 0.77
BAXS's P/S is ranked higher than
92% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.91 vs. BAXS: 0.77 )
BAXS' s 10-Year P/S Range
Min: 0.77   Max: 8.6
Current: 0.77

0.77
8.6
EV-to-EBIT -0.69
BAXS's EV-to-EBIT is ranked higher than
53% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.59 vs. BAXS: -0.69 )
BAXS' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: -0.69

Current Ratio 1.28
BAXS's Current Ratio is ranked higher than
55% of the 223 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.00 vs. BAXS: 1.28 )
BAXS' s 10-Year Current Ratio Range
Min: 1.28   Max: 47.19
Current: 1.28

1.28
47.19
Quick Ratio 0.59
BAXS's Quick Ratio is ranked higher than
50% of the 223 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.09 vs. BAXS: 0.59 )
BAXS' s 10-Year Quick Ratio Range
Min: 0.59   Max: 46.17
Current: 0.59

0.59
46.17

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.23
BAXS's Price/Median PS Value is ranked higher than
99% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. BAXS: 0.23 )
BAXS' s 10-Year Price/Median PS Value Range
Min: 0.48   Max: 2.46
Current: 0.23

0.48
2.46
Forward Rate of Return (Yacktman) -188.32
BAXS's Forward Rate of Return (Yacktman) is ranked lower than
51% of the 259 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.15 vs. BAXS: -188.32 )
BAXS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 17.3   Max: 21.3
Current: -188.32

17.3
21.3

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Baxano Surgical Inc designs, develops and markets products to treat degenerative conditions of the spine affecting the lumbar region.
» More Articles for BAXS

Headlines

Articles On GuruFocus.com
comment on TSON Jan 25 2012 
Weekly CFO Buys Highlight: TSON, VRX, POL, PRTS, EXAM Dec 12 2011 
Weekly CFO Buys Highlight: TSON, PRTS, FXCM, AMRI, MN Dec 05 2011 
Weekly CFO Buys Highlight: CETV, TSON, UCBI, RONE, GTEC Nov 21 2010 
TranS1 Inc. (TSON) CFO Joseph P Slattery buys 10,000 Shares Nov 15 2010 
TranS1 Inc. Reports Operating Results (10-Q) Nov 10 2010 
TranS1 Inc. (TSON) CFO Joseph P Slattery buys 1,200 Shares Sep 08 2010 
TranS1 Inc. (TSON) CFO Joseph P Slattery buys 2,800 Shares Aug 10 2010 
TranS1 Inc. Reports Operating Results (10-Q) Aug 06 2010 
TranS1 Inc. (TSON) CEO Richard D Randall sells 100,000 Shares May 27 2010 

More From Other Websites
BAXANO SURGICAL, INC. Financials Aug 22 2014
BAXANO SURGICAL, INC. Files SEC form 10-Q, Quarterly Report Aug 14 2014
BAXANO SURGICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 05 2014
Baxano Surgical, Inc. Reports Operating Results for the Second Quarter of 2014, Issues Third Quarter... Aug 05 2014
Baxano Surgical, Inc. Announces Two New Patents for VEO Direct Lateral and AxiaLIF Minimally... Aug 05 2014
Q2 2014 Baxano Surgical Inc Earnings Release - After Market Close Aug 05 2014
Baxano Surgical Announces Second Quarter 2014 Earnings Conference Call and Webcast Jul 24 2014
Economic Analysis of Minimally Invasive Spine Fusion Using AxiaLIF Accepted for Publication in the... Jul 18 2014
BAXANO SURGICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jul 14 2014
Baxano Surgical Announces First Clinical Use of the Avance MIS Pedicle Screw System Jun 30 2014
Baxano Surgical to Present at JMP Securities Healthcare Conference Jun 16 2014
BAXANO SURGICAL, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Jun 06 2014
BAXANO SURGICAL, INC. Files SEC form 10-Q, Quarterly Report May 13 2014
Baxano Surgical price target lowered to $2.50 from $3.50 at JMP Securities May 12 2014
Baxano Surgical's (BAXS) CEO Ken Reali on Q1 2014 Results - Earnings Call Transcript May 09 2014
Baxano Surgical sees Q2 revenue $4.4M-$4.8M, consensus $6.67M May 08 2014
Baxano Surgical reports Q1 EPS ex-items (19c), consensus (12c) May 08 2014
BAXANO SURGICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 08 2014
BAXANO SURGICAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Apr 17 2014
Baxano Surgical, Inc. (BAXS) in Focus: Stock up 10.7% Apr 11 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide